Hematology/Oncology News

Patients with sickle cell disease who had non-myeloablative hematopoietic cell transplants had similar or better lung function 3 years later, according to results published in Annals of the American Thoracic Society.

In 2021, Jessica Sheth Bhutada, MD, MS, and colleagues uncovered a startling 2% annual uptick in metastatic stomach cancer in young adults, despite declining rates in older adults. Three years later, they are still trying to understand why.

Cabozantinib significantly improved PFS for patients with previously treated, progressive advanced extrapancreatic or pancreatic neuroendocrine tumors, according to phase 3 study results presented at ESMO Congress.

ASH has announced its three inaugural quality improvement champions.

Olanzapine reduced severe nausea more effectively than prochlorperazine for patients with refractory symptoms after chemotherapy, according to results of a randomized phase 3 trial.

Findings presented at ASCO Quality Care Symposium provided new insights into the effects last year’s cisplatin shortage had on patients with head and neck cancer.

CHICAGO — In this Healio video exclusive, Rebecca Levine, MD, talks finding balance between motherhood and medicine during the Women in Medicine Summit.

The FDA approved osimertinib for treatment of certain patients with locally advanced or unresectable non-small cell lung cancer.

Chimeric antigen receptor T-cell therapy exhibited activity with minimal adverse effects for men with advanced prostate cancer, findings of a first-in-human trial showed.

Women with breast cancer are at risk for lymphedema long after their treatment concludes, according to study findings.